Aspira Womens Health Inc
For the period ended Mar 31, 2024. Filed May 15, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 15, 2024
AWHL$0.430.0%Stored close · as of Sep 19, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item
Condensed Consolidated Balance Sheets (unaudited)
(Amounts in Thousands, Except Share and Par Value Amounts)
| March 31, | December 31, | |
|---|---|---|
| 2024 | 2023 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $3,413 | $2,597 |
| Accounts receivable, net of reserves of $2 and $15, as of March 31, 2024 and December 31, 2023, respectively | 1,531 | 1,459 |
| Prepaid expenses and other current assets | 942 | 997 |
| Inventories | 236 | 227 |
| Total current assets | 6,122 | 5,280 |
| Property and equipment, net | 131 | 165 |
| Right-of-use assets | 620 | 528 |
| Restricted cash | 260 | 258 |
| Other assets | 31 | 31 |
| Total assets | $7,164 | $6,262 |
| Liabilities and Stockholders’ Deficit | ||
| Current liabilities: | ||
| Accounts payable | $1,643 | $1,261 |
| Accrued liabilities | 2,797 | 2,863 |
| Current portion of long-term debt | 249 | 166 |
| Short-term debt | 416 | 670 |
| Current maturities of lease liabilities | 188 | 159 |
| Total current liabilities | 5,293 | 5,119 |
| Non-current liabilities: | ||
| Long-term debt | 1,347 | 1,430 |
| Non-current maturities of lease liabilities | 487 | 427 |
| Warrant liabilities | 1,400 | 1,651 |
| Total liabilities | 8,527 | 8,627 |
| Commitments and contingencies (Note 4) | ||
| Stockholders’ deficit: | ||
| Common stock, par value $0.001 per share, 200,000,000 and 150,000,000 shares authorized at March 31, 2024 and December 31, 2023, respectively; 12,344,104 and 10,645,049 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively | 12 | 11 |
| Additional paid-in capital | 521,557 | 515,927 |
| Accumulated deficit | (522,932) | (518,303) |
| Total stockholders’ deficit | (1,363) | (2,365) |
| Total liabilities and stockholders’ deficit | $7,164 | $6,262 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.